Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125259701 | 12525970 | 1 | I | 20160621 | 20160705 | 20160705 | EXP | GB-AUROBINDO-AUR-APL-2016-08293 | AUROBINDO | 77.00 | YR | M | Y | 0.00000 | 20160705 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125259701 | 12525970 | 1 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 80 MG, ONCE A DAY | N | U | 0 | 80 | MG | QD | |||||
| 125259701 | 12525970 | 2 | PS | Losartan 100mg | LOSARTAN | 1 | Oral | 100 MG, ONCE A DAY | N | U | 90083 | 100 | MG | QD | |||||
| 125259701 | 12525970 | 3 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, ONCE A DAY | N | U | 0 | 25 | MG | QD | |||||
| 125259701 | 12525970 | 4 | C | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, TWO TIMES A DAY | U | 0 | 2.5 | MG | BID | ||||||
| 125259701 | 12525970 | 5 | C | AMIODARONE | AMIODARONE | 1 | Oral | 200 MG, ONCE A DAY | U | 0 | 200 | MG | QD | ||||||
| 125259701 | 12525970 | 6 | C | NICORANDIL | NICORANDIL | 1 | Oral | 10 MG, TWO TIMES A DAY | U | 0 | 10 | MG | BID | ||||||
| 125259701 | 12525970 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, ONCE A DAY | U | 0 | 300 | MG | QD | ||||||
| 125259701 | 12525970 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, ONCE A DAY | U | 0 | 15 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125259701 | 12525970 | 1 | Cardiac failure congestive |
| 125259701 | 12525970 | 2 | Hypertension |
| 125259701 | 12525970 | 3 | Cardiac failure congestive |
| 125259701 | 12525970 | 4 | Atrial fibrillation |
| 125259701 | 12525970 | 5 | Atrial fibrillation |
| 125259701 | 12525970 | 6 | Myocardial ischaemia |
| 125259701 | 12525970 | 7 | Gout |
| 125259701 | 12525970 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125259701 | 12525970 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125259701 | 12525970 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |